Means Investment Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $984K | Sell |
17,080
-429
| -2% | -$24.6K | 0.07% | 90 |
|
|
2026
Q1 | $1.06M | Sell |
17,509
-535
| -3% | -$31.2K | 0.09% | 82 |
|
|
2025
Q4 | $973K | Sell |
18,044
-3,510
| -16% | -$169K | 0.08% | 88 |
|
|
2025
Q3 | $972K | Sell |
21,554
-1,042
| -5% | -$48.7K | 0.08% | 92 |
|
|
2025
Q2 | $1.05M | Sell |
22,596
-2,709
| -11% | -$133K | 0.1% | 88 |
|
|
2025
Q1 | $1.54M | Sell |
25,305
-4,540
| -15% | -$265K | 0.16% | 66 |
|
|
2024
Q4 | $1.69M | Buy |
29,845
+696
| +2% | +$38.9K | 0.18% | 69 |
|
|
2024
Q3 | $1.51M | Sell |
29,149
-3,397
| -10% | -$159K | 0.17% | 73 |
|
|
2024
Q2 | $1.35M | Sell |
32,546
-1,331
| -4% | -$59.6K | 0.16% | 75 |
|
|
2024
Q1 | $1.84M | Sell |
33,877
-7,017
| -17% | -$357K | 0.24% | 66 |
|
|
2023
Q4 | $2.1M | Sell |
40,894
-9,939
| -20% | -$522K | 0.3% | 57 |
|
|
2023
Q3 | $2.95M | Sell |
50,833
-4,435
| -8% | -$272K | 0.48% | 44 |
|
|
2023
Q2 | $3.53M | Buy |
55,268
+938
| +2% | +$62.9K | 0.56% | 41 |
|
|
2023
Q1 | $3.77M | Sell |
54,330
-18
| -0% | -$1.27K | 0.66% | 33 |
|
|
2022
Q4 | $3.91M | Sell |
54,348
-372
| -0.7% | -$28K | 0.78% | 30 |
|
|
2022
Q3 | $3.89M | Buy |
54,720
+257
| +0.5% | +$18.6K | 0.84% | 24 |
|
|
2022
Q2 | $4.19M | Buy |
54,463
+470
| +0.9% | +$35.8K | 0.89% | 26 |
|
|
2022
Q1 | $3.94M | Sell |
53,993
-31
| -0.1% | -$2.08K | 0.71% | 29 |
|
|
2021
Q4 | $3.37M | Buy |
54,024
+303
| +0.6% | +$17.8K | 0.59% | 35 |
|
|
2021
Q3 | $3.18M | Buy |
53,721
+2,721
| +5% | +$179K | 0.63% | 34 |
|
|
2021
Q2 | $3.41M | Sell |
51,000
-295
| -0.6% | -$19.2K | 0.68% | 29 |
|
|
2021
Q1 | $3.24M | Sell |
51,295
-3,236
| -6% | -$201K | 0.74% | 28 |
|
|
2020
Q4 | $3.27M | Buy |
54,531
+76
| +0.1% | +$4.67K | 0.75% | 26 |
|
|
2020
Q3 | $3.47M | Sell |
54,455
-899
| -2% | -$54.1K | 0.95% | 21 |
|
|
2020
Q2 | $3.49M | Buy |
55,354
+402
| +0.7% | +$24K | 1.09% | 17 |
|
|
2020
Q1 | $3.35M | Sell |
54,952
-2,001
| -4% | -$122K | 1.3% | 18 |
|
|
2019
Q4 | $3.8M | Buy |
56,953
+9,018
| +19% | +$516K | 1.27% | 18 |
|
|
2019
Q3 | $2.71M | Buy |
47,935
+874
| +2% | +$41.1K | 1.03% | 25 |
|
|
2019
Q2 | $2.17M | Sell |
47,061
-1,613
| -3% | -$75.1K | 0.89% | 35 |
|
|
2019
Q1 | $2.32M | Buy |
48,674
+4,727
| +11% | +$235K | 1.02% | 30 |
|
|
2018
Q4 | $2.28M | Buy |
+43,947
| New | +$2.36M | 1.26% | 20 |
|
Other funds holding BMY
Means Investment Company's BMY Position: Q2 2026 in Review
Means Investment Company reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $24.6K and leaving 17,080 shares worth $984K. The position accounts for 0.07% of the portfolio, ranked #90.
Means Investment Company first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.19M in Q2 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Means Investment Company held 17,080 shares of Bristol-Myers Squibb worth $984K as of Q2 2026.
- Means Investment Company sold 429 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.6K.
- Bristol-Myers Squibb made up 0.07% of Means Investment Company's portfolio in Q2 2026, its #90 holding.
- Means Investment Company first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- Means Investment Company's Bristol-Myers Squibb position peaked at $4.19M in Q2 2022.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.